CB
Cue Biopharma
🇺🇸XNAS.CUEUnited StatesHealthcare
$34.17USDup +2.50 (+7.89%)ClosedDelayed7:41 AM
Price$34.17+2.50 (+7.89%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US22978P2056
- CUSIP
- 22978P106
Company
- Employees
- 29
- Headquarters
- Boston, United States
- Website
- https://www.cuebiopharma.com
- CEO
- Dr. Shao-Lee Lin M.D., Ph.D.
Market
- Shares outstanding
- 7.3M
- Market cap
- $248.23M
Highlights
- Market cap
- $248.23M
- EPS LTM
- -$25.88
- P/E LTM
- -1.28
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $37.65M+354.37%up year on year
- Net income
- -$164.11M-321.93%down year on year
- Gross margin
- 90.98%-6.83%down year on year
- Free cash flow
- -$50.17M-77.14%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.